KOREA PHARM&BIO 2026: Where Global Pharma Meets AI and Biotech Innovation

From March 31 to April 3, 2026, the global pharmaceutical and biopharmaceutical community will gather at KINTEX in Goyang-si for one of Asia's most influential industry platforms. As Korea's leading exhibition and conference dedicated to the pharmaceutical and bio-health sector, KOREA PHARM&BIO 2026 is set to spotlight cutting-edge technologies, strategic policy insights, and next-generation healthcare solutions shaping the future of global life sciences.

A Strategic Hub for the Global Pharma-Bio Ecosystem

Amid accelerating digital transformation, precision medicine breakthroughs, and expanding cross-border R&D collaboration, the pharmaceutical landscape is undergoing structural change. KOREA PHARM&BIO 2026 positions itself at the center of this evolution, offering an integrated platform that spans the entire industry value chain — from active pharmaceutical ingredients (APIs) and finished dosage formulations to AI-powered drug discovery and smart healthcare systems.

The exhibition is distinguished by its comprehensive scope, sector-focused showcases, and a dynamic program of concurrent conferences and forums. It is designed not only as a trade exhibition but as a knowledge-driven ecosystem where innovation, regulation, investment, and commercialization converge.

Comprehensive Industry Coverage Across Eight Core Sectors

KOREA PHARM&BIO 2026 presents a broad and highly specialized exhibition portfolio:

• Pharmaceuticals & Ingredients

APIs, intermediates, excipients and formulations, fine chemicals, functional ingredients, and natural extracts will be showcased alongside finished dosage innovations — reflecting the continued modernization of pharmaceutical manufacturing and sourcing strategies.

• Biopharmaceuticals

With biosimilars, biotechnology services, bio clusters, and bio logistics in focus, this sector highlights Korea's growing leadership in biologics production and global CDMO expansion.

• Contract Services & Outsourcing

CMOs, CROs, pre-clinical and Phase I–IV clinical trials, bioequivalence testing, analytical and laboratory services, and clinical data management providers will demonstrate scalable and compliant outsourcing solutions for global sponsors.

• Health Ingredients

Natural and functional ingredients, health supplements, and additives underscore the increasing convergence between pharmaceuticals and nutraceuticals in preventive healthcare.

• Analytical, Consulting & IT Services

Advanced pharmaceutical laboratory equipment, regulatory consulting, IT platforms, intellectual property and patent law services, investor relations advisory, and pharmaceutical logistics solutions form a critical backbone for compliant and efficient operations.

• Smart Healthcare

A major highlight of the 2026 edition, this sector features personalized medicine, digital therapeutics, next-generation diagnostics, telemedicine platforms, advanced genetic research, high-tech imaging, bio-organization reconstruction, and wearable medical devices — demonstrating how data and connectivity are redefining patient care.

• Pharmaceutical & Bio New Technology

From pharmaceutical equipment and new drug discovery technologies to gene analysis, AI-driven deep learning platforms, ICT integration, new materials, and 3D printing, exhibitors will present transformative tools accelerating time-to-market and research precision.

• Institutes, Associations & Media

Research institutes, government organizations, industry associations, and specialized media outlets will facilitate policy dialogue, global cooperation, and sector-wide visibility.

High-Level Conferences Driving Policy and Strategy Dialogue

Complementing the exhibition floor, KOREA PHARM&BIO 2026 will host a robust conference and seminar agenda, reinforcing its role as both a marketplace and an intellectual forum.

Key programs include:

• MFDS Pharmaceutical & Bio-Pharma Policy Seminar

• Pharm & Bio-health Business Development Strategy Forum

• Technology Transfer & IR Forum

• International Forum on Pharmaceutical & Bio-Pharma Business

• Data Integrity & LIMS Conference

• Biz-Matching Program

• Micro-needle Convergence Seminar

• Exhibitor New Technology & Product Seminar

These sessions will address regulatory frameworks, global market access, digital compliance systems, data integrity standards, investment strategy, and cross-border technology transfer — topics critical to navigating today's complex pharmaceutical environment.

Why KOREA PHARM&BIO 2026 Matters

1. Diverse Concurrent Events

Multiple high-level forums and specialized seminars enhance knowledge exchange and partnership building.

2. Focus on Cutting-Edge Trends

AI, gene analysis, digital therapeutics, and smart healthcare innovations define the 2026 agenda.

2. Deep Industry Specialization

Sector-focused exhibition zones enable precise networking and targeted sourcing.

As Asia's pharmaceutical and biotechnology industries continue to expand in scale and sophistication, KOREA PHARM&BIO 2026 stands out as a strategic gateway for global stakeholders seeking market intelligence, regulatory insight, and long-term partnerships in the Korean and wider Asia-Pacific markets.

With innovation accelerating and global collaboration becoming indispensable, KOREA PHARM&BIO 2026 is poised to be a defining meeting point for the next chapter of pharmaceutical and bio-health advancement.

Event Details:

Dates: March 31–April 3, 2026 

Location: KINTEX (Korea International Exhibition), Goyang-si

Website: https://koreapharm.org/